Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2010

Oct 5, 2010

33819_dirs_2010-10-05_1d5bdc7a-dc3a-4216-8e5a-e22aad2dc2a0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2010-10-01

Reporting Person: WEISSMAN IRVING (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-10-01 Common Stock A 3465 $0.25 Acquired 342881 Direct
2010-10-01 Common Stock A 10000 $0.00 Acquired 352881 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 190111 Indirect

Footnotes

F1: The $0.25 per share price was the stock option exercise price for shares granted to Dr. Weissman on October 6, 2000, November 3, 2000, December 31, 2000 and January 2, 2001.

F2: Includes (1) exercise of shares granted to Dr. Weissman on October 6, 2000, November 3, 2000, December 31, 2000 and January 2, 2001, and (2) anniversary equity grant of 10,000 restricted stock units, vesting 100% on October 1, 2011, the one year anniversary of the grant.

F3: 105,079 shares held in trust as to which Dr. Weissman disclaims beneficial ownership.